Riversource Lasalle International Real Estate Fund Inc. (SLS)

Sellas Life Sciences (NASDAQ:SLS) saw its share price decline by 13.15 percent on Friday to close at $13.21 apiece, as investors turned increasingly concerned about the company’s silence about its treatment...

SELLAS Life Sciences stock was a hot topic among retail traders on Monday as the company is getting closer to reporting data from its Phase 3 REGAL...

Sellas Life Sciences bounced back by 12.26 percent on Friday to close at $13.19 apiece, as investors positioned portfolios ahead of a potentially company-defining clinical data release, supported by takeover...

In this article, we will look at the 10 Best Performing American Stocks in June 2026.

Ten stocks kicked off the shortened trading week with strong double-digit gains, mirroring a rally in the broader market buoyed by the US and Iran’s decision to end hostilities.

Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on SLS.

Nine stocks clocked strong double-digit gains on Thursday, bucking a lackluster performance in the broader market, thanks to stellar earnings performance and acquisition news that sparked buying appetite...

What started as a pandemic lockdown pastime has become a force Wall Street can't ignore.

In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money, as he explained that many investors might be missing out on the market’s biggest winners.